Former Interim Chief Executive Officer and former Acting Head of Research and Development · Passage BIO, Inc. (PASG)

Stephen Squinto

A named executive officer of Passage BIO in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$3,764,932

Salary $246,000Stock awards $0

FY2019: $2,140,351

3rd of 4 named executive officers at Passage BIO by FY2020 total.

4 named officers on file for Passage BIO, FY2020

Stephen Squinto’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • PASG’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Passage BIO’s whole pay program stands against its peers

  • Passage BIO’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PASG→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 14, 2021 (DEF 14A).

Free

Get Stephen Squinto’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Stephen Squinto compensation by year

Passage BIO Summary Compensation Table · all 2 fiscal years held
In US dollars, as Passage BIO reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$225,000$246,000
Bonus$0$0
Stock awards$0$0
Option awards$1,787,945$2,977,939
Non-equity incentive$127,406$0
Pension and deferred compensation$0$0
All other$0$540,993
Total$2,140,351$3,764,932

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Passage BIO, Inc. DEF 14A filed April 14, 2021, accession 0001558370-21-004266, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Passage BIO, Inc. filed document, accession 0001558370-21-004266. Every figure is read from that document and cited to the page and table it appears in. Filed April 14, 2021.

$2.1M
$3.8M
FY19
FY20
SalaryNon-equity incentiveOption awardsAll other

Passage BIO’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Bruce GoldsmithChief Executive Officer and President$16,707,075
Jill QuigleyFormer Chief Operating Officer$4,388,169
Stephen Squinto · this pageFormer Interim Chief Executive Officer and former Acting Head of Research and Development$3,764,932
Gary RomanoChief Medical Officer$2,198,312

The full Passage BIO compensation record

free company brief

This page is one person within Passage BIO's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Passage BIO's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stephen Squinto's compensation dossier · One-time report. No refunds.